Compare Nuwellis Inc (NUWE) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Revvity Inc — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Revvity Inc is far larger — about 10889.9× Nuwellis Inc's market cap, and Revvity Inc pays a 0.26% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | RVTY | |
|---|---|---|
Market Cap | $1.09M | $11.87B |
Sector | Technology | Technology |
52-Week High | $527.46 | $117.75 |
52-Week Low | $2.80 | $82.26 |
Enterprise Value | -$722.58K | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
